MENU
+Compare
INAB
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$2.13
Change
-$0.03 (-1.39%)
Capitalization
7.37M

INAB IN8bio Inc Forecast, Technical & Fundamental Analysis

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells... Show more

INAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for INAB with price predictions
Jun 27, 2025

INAB in upward trend: price may ascend as a result of having broken its lower Bollinger Band on June 09, 2025

INAB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 31 cases where INAB's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for INAB just turned positive on June 27, 2025. Looking at past instances where INAB's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INAB advanced for three days, in of 155 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 09, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on INAB as a result. In of 61 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INAB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for INAB entered a downward trend on June 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.529) is normal, around the industry mean (16.326). P/E Ratio (0.000) is within average values for comparable stocks, (58.407). INAB's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.310). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.768).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. INAB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
INAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

INAB is expected to report earnings to fall 17.86% to -5 cents per share on August 07

IN8bio Inc INAB Stock Earnings Reports
Q2'25
Est.
$-0.06
Q1'25
Est.
$-0.07
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.02
The last earnings report on May 07 showed earnings per share of -7 cents, beating the estimate of -7 cents. With 134.75K shares outstanding, the current market capitalization sits at 7.37M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
350 5th Avenue
Phone
+1 646 600-6438
Employees
31
Web
https://www.in8bio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APG50.870.56
+1.11%
APi Group Corp
RLX2.220.02
+0.91%
RLX Technology
FLGT19.680.08
+0.41%
Fulgent Genetics
APM0.97-0.02
-1.87%
Aptorum Group Limited
SOL1.84-0.06
-3.16%
Emeren Group Ltd

INAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INAB has been loosely correlated with IDYA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if INAB jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INAB
1D Price
Change %
INAB100%
-0.93%
IDYA - INAB
47%
Loosely correlated
-4.04%
SNSE - INAB
40%
Loosely correlated
+3.58%
GRI - INAB
36%
Loosely correlated
-1.17%
CUE - INAB
31%
Poorly correlated
-5.22%
SRZN - INAB
28%
Poorly correlated
+7.76%
More